RenovoRx announced that Ryan Witt has joined the Company in the new role as Senior Vice President, Head of Corporate Strategy and Partnerships. Witt, who has been a consultant to the Company for the past year, has a strong track record, backed by 15 years of experience, in successfully leading corporate strategy in both medical technology and biopharmaceutical companies.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNXT:
- RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
- RenovoRx Shareholders Unanimously Elect Board Directors
- RenovoRx CEO issues update letter to shareholders
- RenovoRx: Efficacy/drug delivery potential of TAMP improve cancer therapy
- Biopharmaceutical Challenger Renovorx: Navigating Uncertainty and Financial Risks in Drug Development